- Double bottom, creating bullish divergence on lower time frames - Bullish divergence on macro time frames - Strong macro support - Insane increase of insider transaction, indicating probably good earning.
Chiasma Inc is a biopharmaceutical company that focuses on improving the lives of patients who face challenges associated with existing treatments for their rare and debilitating diseases. Its product candidate includes octreotide capsule which has completed Phase III clinical trial and it is being developed for the potential treatment of acromegaly, a rare,...
$CHMA (Chiasma) Long at support with bullish divergences
CHMA has broken a lower degree downtrend but there is the 3$ level to break. Wait fo a solid breakout of the 3$ level before entering long.